학술논문

The Stroke Prevention Programme: a programme of research to inform optimal stroke prevention in primary care
Document Type
article
Source
Programme Grants for Applied Research, Vol 4, Iss 3 (2016)
Subject
stroke prevention
primary care
blood pressure monitoring
polypill
self-management
mixed methods
Public aspects of medicine
RA1-1270
Language
English
ISSN
2050-4322
2050-4330
Abstract
Background: The management of cardiovascular (CV) risk factors in community populations is suboptimal. The aim of this programme was to explore the role of three approaches [use of a ‘polypill’; self-management of hypertension; and more intensive targets for blood pressure (BP) lowering after stroke] to improve prevention of CV disease (CVD) in the community. Research questions: (1) Is it more cost-effective to titrate treatments to target levels of cholesterol and BP or to use fixed doses of statins and BP-lowering agents (polypill strategy)? (2) Will telemonitoring and self-management improve BP control in people on treatment for hypertension or with a history of stroke/transient ischaemic attack (TIA) in primary care and are they cost-effective? (3) In people with a history of stroke/TIA, can intensive BP-lowering targets be achieved in a primary care setting and what impact will this have on health outcomes and cost-effectiveness? Design: Mixed methods, comprising three randomised controlled trials (RCTs); five cost-effectiveness analyses; qualitative studies; analysis of electronic general practice data; a screening study; a systematic review; and a questionnaire study. Setting: UK general practices, predominantly from the West Midlands and the east of England. Participants: Adults registered with participating general practices. Inclusion criteria varied from study to study. Interventions: A polypill – a fixed-dose combination pill containing three antihypertensive medicines and simvastatin – compared with current practice and with optimal implementation of national guidelines; self-monitoring of BP with self-titration of medication, compared with usual care; and an intensive target for systolic BP of